Request Sample Inquiry
Dystrophin Market

Dystrophin Market

Dystrophin Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

168

Base Year:

2022

Date

Jan - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1251

Segments Covered
  • By Product By Product Exondys51, Translarna, Emflaza, Others
  • By Approach By Approach Exon Skipping, Anti-Inflammatory Therapy, Stop Codon Read-Through, Others Approaches
  • By Region By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1.46 Billion
Revenue 2030Revenue 2030: USD 29.53 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 45.60%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Dystrophin Market Segment Analysis

  • Dystrophin Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Exondys51
    • Translarna
    • Emflaza
    • Others
  • Dystrophin Approach Outlook (Revenue, USD Million, 2018 - 2030)
    • Exon Skipping
    • Anti-Inflammatory Therapy
    • Stop Codon Read-Through
    • Others Approaches
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Dystrophin Market, by Product
        • Exondys51
        • Translarna
        • Emflaza
        • Others
      • North America Dystrophin Market, by Approach
        • Exon Skipping
        • Anti-Inflammatory Therapy
        • Stop Codon Read-Through
        • Others Approaches
      • U.S.
        • U.S. Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • U.S. Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Canada
        • Canada Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Canada Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Mexico
        • Mexico Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Mexico Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
    • Europe
      • Europe Dystrophin Market, by Product
        • Exondys51
        • Translarna
        • Emflaza
        • Others
      • Europe Dystrophin Market, by Approach
        • Exon Skipping
        • Anti-Inflammatory Therapy
        • Stop Codon Read-Through
        • Others Approaches
      • U. K.
        • U.K. Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • U.K. Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • France
        • France Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • France Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Germany
        • Germany Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Germany Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Italy
        • Italy Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Italy Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Spain
        • Spain Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Spain Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Rest of Europe
        • Rest of Europe Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Rest of Europe Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
    • Asia Pacific
      • Asia Pacific Dystrophin Market, by Product
        • Exondys51
        • Translarna
        • Emflaza
        • Others
      • Asia Pacific Dystrophin Market, by Approach
        • Exon Skipping
        • Anti-Inflammatory Therapy
        • Stop Codon Read-Through
        • Others Approaches
      • China
        • China Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • China Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Japan
        • Japan Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Japan Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Germany
        • Germany Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Germany Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • India
        • India Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • India Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • South Korea
        • South Korea Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • South Korea Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • South East Asia
        • South East Asia Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • South East Asia Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Rest of Asia Pacific
        • Rest of Asia Pacific Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Rest of Asia Pacific Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
    • Latin America
      • Latin America Dystrophin Market, by Product
        • Exondys51
        • Translarna
        • Emflaza
        • Others
      • Latin America Dystrophin Market, by Approach
        • Exon Skipping
        • Anti-Inflammatory Therapy
        • Stop Codon Read-Through
        • Others Approaches
      • Brazil
        • Brazil Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Brazil Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Argentina
        • Argentina Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Argentina Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Rest of Latin America
        • Rest of Latin America Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Rest of Latin America Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
    • Middle East & Africa
      • Middle East & Africa Dystrophin Market, by Product
        • Exondys51
        • Translarna
        • Emflaza
        • Others
      • Middle East & Africa Dystrophin Market, by Approach
        • Exon Skipping
        • Anti-Inflammatory Therapy
        • Stop Codon Read-Through
        • Others Approaches
      • GCC Countries
        • GCC Countries Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • GCC Countries Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • South Africa
        • South Africa Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • South Africa Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Dystrophin Market, by Product
          • Exondys51
          • Translarna
          • Emflaza
          • Others
        • Rest of Middle East & Africa Dystrophin Market, by Approach
          • Exon Skipping
          • Anti-Inflammatory Therapy
          • Stop Codon Read-Through
          • Others Approaches
FAQ
Frequently Asked Question
  • The global Dystrophin valued at USD 1.46 Billion in 2022 and is expected to reach USD 29.53 Billion in 2030 growing at a CAGR of 45.60%.

  • The prominent players in the market are PTC Therapeutics, Sarepta Therapeutics, BioMarin Pharmaceutical Inc, Wave Life Sciences, Bristol-Myers Squibb and Catabasis, Pharmaceuticals among others..

  • The market is project to grow at a CAGR of 45.60% between 2023 and 2030.

  • The driving factors of the Dystrophin include

    • Emergence of Mutation-Specific Therapies, Rising Incidence of the Condition, and Improved Diagnostics

  • North America was the leading regional segment of the Dystrophin in 2022.